Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation

✍ Scribed by Brando Lima, Aline C.; Machado, Alexandre L.; Simon, Patrícia; Cavalcante, Moisés M.; Rezende, Daniele C.; Sperandio da Silva, Gilberto M.; Nascimento, Paulo Gustavo B.D.; Quintas, Luis E.M.; Cunha, Fernando Q.; Barreiro, Eliezer J.; Lima, Lídia M.; Koatz, Vera L.G.

• Book ID: 123019924
• Publisher: Elsevier
• Year: 2011
• Tongue: English
• Weight: 730 KB
• Volume: 63
• Category: Article
• ISSN: 1734-1140
• DOI: 10.1016/S1734-1140(11)70619-3